664 related articles for article (PubMed ID: 27638904)
1. Protective effect of suppressing STAT3 activity in LPS-induced acute lung injury.
Zhao J; Yu H; Liu Y; Gibson SA; Yan Z; Xu X; Gaggar A; Li PK; Li C; Wei S; Benveniste EN; Qin H
Am J Physiol Lung Cell Mol Physiol; 2016 Nov; 311(5):L868-L880. PubMed ID: 27638904
[TBL] [Abstract][Full Text] [Related]
2. Resveratrol decreases CD45
Hu L; Chen Z; Li L; Jiang Z; Zhu L
J Cell Mol Med; 2019 Dec; 23(12):8101-8113. PubMed ID: 31559687
[TBL] [Abstract][Full Text] [Related]
3. Elevated IL-33 promotes expression of MMP2 and MMP9 via activating STAT3 in alveolar macrophages during LPS-induced acute lung injury.
Liang Y; Yang N; Pan G; Jin B; Wang S; Ji W
Cell Mol Biol Lett; 2018; 23():52. PubMed ID: 30410547
[TBL] [Abstract][Full Text] [Related]
4. Lack of SOCS3 increases LPS-induced murine acute lung injury through modulation of Ly6C(+) macrophages.
Jiang Z; Chen Z; Li L; Zhou W; Zhu L
Respir Res; 2017 Dec; 18(1):217. PubMed ID: 29284516
[TBL] [Abstract][Full Text] [Related]
5. Anti-inflammatory effects of novel curcumin analogs in experimental acute lung injury.
Zhang Y; Liang D; Dong L; Ge X; Xu F; Chen W; Dai Y; Li H; Zou P; Yang S; Liang G
Respir Res; 2015 Mar; 16(1):43. PubMed ID: 25889862
[TBL] [Abstract][Full Text] [Related]
6. The STAT3 inhibitor B9 alleviates lipopolysaccharide-induced acute lung injury through its anti-inflammatory effects.
Cao L; Song H; Zhou S; Lan K; Lv K; Huang M
Int Immunopharmacol; 2024 Jun; 135():112221. PubMed ID: 38762924
[TBL] [Abstract][Full Text] [Related]
7. Myeloid depletion of SOCS3 enhances LPS-induced acute lung injury through CCAAT/enhancer binding protein δ pathway.
Yan C; Ward PA; Wang X; Gao H
FASEB J; 2013 Aug; 27(8):2967-76. PubMed ID: 23585399
[TBL] [Abstract][Full Text] [Related]
8. Geranylgeranyl diphosphate synthase deficiency hyperactivates macrophages and aggravates lipopolysaccharide-induced acute lung injury.
Jin J; Qian H; Wan B; Zhou L; Chen C; Lv Y; Chen M; Zhu S; Ye L; Wang X; Xu W; Lv T; Song Y
Am J Physiol Lung Cell Mol Physiol; 2021 Jun; 320(6):L1011-L1024. PubMed ID: 33729030
[TBL] [Abstract][Full Text] [Related]
9. Activation of the IL-1β/KLF2/HSPH1 pathway promotes STAT3 phosphorylation in alveolar macrophages during LPS-induced acute lung injury.
Liang Y; Luo J; Yang N; Wang S; Ye M; Pan G
Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32091104
[TBL] [Abstract][Full Text] [Related]
10. AKR1C1 alleviates LPS‑induced ALI in mice by activating the JAK2/STAT3 signaling pathway.
Wang X; Yang B; Li Y; Luo J; Wang Y
Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34590152
[TBL] [Abstract][Full Text] [Related]
11. Anti-inflammatory action of Athyrium multidentatum extract suppresses the LPS-induced TLR4 signaling pathway.
Han XZ; Ma R; Chen Q; Jin X; Jin YZ; An RB; Piao XM; Lian ML; Quan LH; Jiang J
J Ethnopharmacol; 2018 May; 217():220-227. PubMed ID: 29476961
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Pendrin by a small molecule reduces Lipopolysaccharide-induced acute Lung Injury.
Lee EH; Shin MH; Gi M; Park J; Song D; Hyun YM; Ryu JH; Seong JK; Jeon Y; Han G; Namkung W; Park MS; Choi JY
Theranostics; 2020; 10(22):9913-9922. PubMed ID: 32929324
[No Abstract] [Full Text] [Related]
13. Lower Oligomeric Form of Surfactant Protein D in Murine Acute Lung Injury Induces M1 Subtype Macrophages Through Calreticulin/p38 MAPK Signaling Pathway.
Li D; Pan L; Zhang X; Jiang Z
Front Immunol; 2021; 12():687506. PubMed ID: 34484184
[TBL] [Abstract][Full Text] [Related]
14. Sophoricoside attenuates lipopolysaccharide-induced acute lung injury by activating the AMPK/Nrf2 signaling axis.
Wu YX; Zeng S; Wan BB; Wang YY; Sun HX; Liu G; Gao ZQ; Chen D; Chen YQ; Lu MD; Pang QF
Int Immunopharmacol; 2021 Jan; 90():107187. PubMed ID: 33249045
[TBL] [Abstract][Full Text] [Related]
15. Protective effects of intratracheally administered quercetin on lipopolysaccharide-induced acute lung injury.
Takashima K; Matsushima M; Hashimoto K; Nose H; Sato M; Hashimoto N; Hasegawa Y; Kawabe T
Respir Res; 2014 Nov; 15(1):150. PubMed ID: 25413579
[TBL] [Abstract][Full Text] [Related]
16. Depletion of circulating monocytes suppresses IL-17 and HMGB1 expression in mice with LPS-induced acute lung injury.
Jiang Z; Zhou Q; Gu C; Li D; Zhu L
Am J Physiol Lung Cell Mol Physiol; 2017 Feb; 312(2):L231-L242. PubMed ID: 27913426
[TBL] [Abstract][Full Text] [Related]
17. MNK as a potential pharmacological target for suppressing LPS-induced acute lung injury in mice.
Gao J; Teng L; Yang S; Huang S; Li L; Zhou L; Liu G; Tang H
Biochem Pharmacol; 2021 Apr; 186():114499. PubMed ID: 33675774
[TBL] [Abstract][Full Text] [Related]
18. Signal transducer and activator of transcription-3/suppressor of cytokine signaling-3 (STAT3/SOCS3) axis in myeloid cells regulates neuroinflammation.
Qin H; Yeh WI; De Sarno P; Holdbrooks AT; Liu Y; Muldowney MT; Reynolds SL; Yanagisawa LL; Fox TH; Park K; Harrington LE; Raman C; Benveniste EN
Proc Natl Acad Sci U S A; 2012 Mar; 109(13):5004-9. PubMed ID: 22411837
[TBL] [Abstract][Full Text] [Related]
19. Fibroblast Growth Factor 21 Relieves Lipopolysaccharide-Induced Acute Lung Injury by Suppressing JAK2/STAT3 Signaling Pathway.
Cai M; Ye H; Zhu X; Li X; Cai L; Jin J; Chen Q; Shi Y; Yang L; Wang L; Huang X
Inflammation; 2024 Feb; 47(1):209-226. PubMed ID: 37864659
[TBL] [Abstract][Full Text] [Related]
20. Wogonin prevents lipopolysaccharide-induced acute lung injury and inflammation in mice via peroxisome proliferator-activated receptor gamma-mediated attenuation of the nuclear factor-kappaB pathway.
Yao J; Pan D; Zhao Y; Zhao L; Sun J; Wang Y; You QD; Xi T; Guo QL; Lu N
Immunology; 2014 Oct; 143(2):241-57. PubMed ID: 24766487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
